Champlain Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDLA
Medallia, Inc.
MDLA
|
+$127M |
| 2 |
DNKN
Dunkin' Brands Group, Inc.
DNKN
|
+$104M |
| 3 |
Zscaler
ZS
|
+$93.7M |
| 4 |
Align Technology
ALGN
|
+$76.5M |
| 5 |
Toro Company
TTC
|
+$68.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$132M |
| 2 |
Teladoc Health
TDOC
|
+$122M |
| 3 |
International Flavors & Fragrances
IFF
|
+$119M |
| 4 |
Blackbaud
BLKB
|
+$98.5M |
| 5 |
Hormel Foods
HRL
|
+$85.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Technology | 21.16% |
| 3 | Financials | 14.01% |
| 4 | Consumer Staples | 13.48% |
| 5 | Industrials | 12.23% |
Similar funds
Champlain Investment Partners's Q1 2020 Portfolio in Review
As of Q1 2020, Champlain Investment Partners held 128 positions worth $11.1B, down 19% from $13.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Champlain Investment Partners deployed $671M of net new capital in Q1 2020, opening 9 new positions and adding to 85 existing holdings. Its largest new stake was Dunkin' Brands Group, Inc.: 1,501,060 shares worth $79.7M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Teladoc Health, an estimated $122M trimmed.
- Champlain Investment Partners's largest Q1 2020 buy was Dunkin' Brands Group, Inc.: 1,501,060 shares worth $79.7M.
- Champlain Investment Partners added most to Medallia, Inc. in Q1 2020, an estimated $127M increase.
- Champlain Investment Partners's biggest Q1 2020 reduction was Teladoc Health, cutting an estimated $122M.
- Champlain Investment Partners fully exited Labcorp in Q1 2020, selling an estimated $132M.
- Champlain Investment Partners's ten largest holdings make up 20% of its $11.1B portfolio in Q1 2020.
- Champlain Investment Partners opened 9 new positions and closed 9 in Q1 2020.
- Champlain Investment Partners's portfolio value fell 19% quarter-over-quarter to $11.1B.
Based on Champlain Investment Partners's 13F filing for Q1 2020, filed 14 May 2020.